12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers

  • Lucid Diagnostics LUCD shares moved upwards by 10.9% to $1.73 during Tuesday's after-market session. The market value of their outstanding shares is at $67.6 million.
  • Nymox Pharmaceutical NYMX stock increased by 10.65% to $0.52. The company's market cap stands at $46.9 million.
  • Artelo Biosciences ARTL shares increased by 9.17% to $3.77. The company's market cap stands at $10.7 million.
  • Regulus Therapeutics RGLS stock rose 8.73% to $1.63. The market value of their outstanding shares is at $27.4 million.
  • Clearside Biomedical CLSD shares increased by 7.38% to $1.6. The market value of their outstanding shares is at $96.3 million.
  • Intelligent Bio Solutions INBS stock rose 5.51% to $0.28. The market value of their outstanding shares is at $5.2 million.

Losers

  • Celyad Oncology CYAD stock decreased by 7.4% to $1.76 during Tuesday's after-market session. This security traded at a volume of 3.8 million shares come close, making up 43311.7% of its average volume over the last 100 days. The market value of their outstanding shares is at $39.7 million.
  • Dermata Therapeutics DRMA stock fell 6.9% to $0.27. The company's market cap stands at $3.3 million.
  • PLx Pharma PLXP stock fell 6.64% to $0.23. The company's market cap stands at $6.5 million.
  • Fulcrum Therapeutics FULC shares decreased by 5.94% to $13.16. The market value of their outstanding shares is at $684.9 million.
  • PAVmed PAVM shares decreased by 5.59% to $0.6. The market value of their outstanding shares is at $56.2 million.
  • Olema Pharmaceuticals OLMA shares fell 4.99% to $4.19. The company's market cap stands at $169.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!